Cadingilan, Rahima D.

HRN: 27-08-44  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2025
CEFUROXIME 500MG (TAB)
05/30/2025
06/06/2025
ORAL
500mg
BID
S/P NSD With Repair
Waiting Final Action 
05/30/2025
CEFUROXIME 1.5GM (VIAL)
05/30/2025
05/31/2025
IV
1.5gms
Q8hrs X 3 Doses
RMLE And Repair
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: